Literature DB >> 28623489

Comparing the Intracarotid Amobarbital Test and Functional MRI for the Presurgical Evaluation of Language in Epilepsy.

Andreu Massot-Tarrús1, Seyed Reza Mousavi2,3, Seyed M Mirsattari4,5,6,7.   

Abstract

Surgery is the treatment of choice for drug-resistant temporal lobe epilepsy (TLE). However, such surgery frequently causes deficits in language function, especially if performed on the dominant hemisphere. In recent years, the intracarotid amobarbital test (IAT) has been gradually replaced by functional magnetic resonance imaging (fMRI) in the preoperative identification of language areas to estimate the risk of postoperative language decline. In this paper, we review the neural substrates for language processing, how language impairment can result both from TLE itself and from surgical attempts to treat it. Subsequently, we discuss the strengths and limitations of, and current indications for fMRI and IAT during the preoperative workup, both by discussion of the studies that have evaluated them individually and through meta-analysis of data from 31 studies deemed eligible for analysis. Electrocortical stimulation mapping (ESM) is also discussed, as is the usefulness of the novel technique of resting-state fMRI. Finally, surgical techniques designed to avoid or reduce language decline in patients at risk are explored.

Entities:  

Keywords:  Intracarotid amobarbital test; Language; Naming; Presurgical evaluation; Resting-state fMRI; fMRI

Mesh:

Substances:

Year:  2017        PMID: 28623489     DOI: 10.1007/s11910-017-0763-9

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  99 in total

Review 1.  Dorsal and ventral streams: a framework for understanding aspects of the functional anatomy of language.

Authors:  Gregory Hickok; David Poeppel
Journal:  Cognition       Date:  2004 May-Jun

2.  Evoked-cerebral blood oxygenation changes in false-negative activations in BOLD contrast functional MRI of patients with brain tumors.

Authors:  Norio Fujiwara; Kaoru Sakatani; Yoichi Katayama; Yoshihiro Murata; Tetsuya Hoshino; Chikashi Fukaya; Takamitsu Yamamoto
Journal:  Neuroimage       Date:  2004-04       Impact factor: 6.556

3.  Location of language in the cortex: a comparison between functional MR imaging and electrocortical stimulation.

Authors:  D B FitzGerald; G R Cosgrove; S Ronner; H Jiang; B R Buchbinder; J W Belliveau; B R Rosen; R R Benson
Journal:  AJNR Am J Neuroradiol       Date:  1997-09       Impact factor: 3.825

4.  Who needs a Wada test? Present clinical indications for amobarbital procedures.

Authors:  Kathrin Wagner; Claudia Hader; Birgitta Metternich; Franziska Buschmann; Ralf Schwarzwald; Andreas Schulze-Bonhage
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-03-06       Impact factor: 10.154

Review 5.  Object naming in epilepsy and epilepsy surgery.

Authors:  Marla J Hamberger
Journal:  Epilepsy Behav       Date:  2015-01-15       Impact factor: 2.937

6.  Functional MR evaluation of temporal and frontal language dominance compared with the Wada test.

Authors:  S Lehéricy; L Cohen; B Bazin; S Samson; E Giacomini; R Rougetet; L Hertz-Pannier; D Le Bihan; C Marsault; M Baulac
Journal:  Neurology       Date:  2000-04-25       Impact factor: 9.910

7.  Language lateralization in epilepsy patients: fMRI validated with the Wada procedure.

Authors:  Jagriti Arora; Kenneth Pugh; Michael Westerveld; Susan Spencer; Dennis D Spencer; R Todd Constable
Journal:  Epilepsia       Date:  2009-06-01       Impact factor: 5.864

8.  Use of preoperative functional neuroimaging to predict language deficits from epilepsy surgery.

Authors:  D S Sabsevitz; S J Swanson; T A Hammeke; M V Spanaki; E T Possing; G L Morris; W M Mueller; J R Binder
Journal:  Neurology       Date:  2003-06-10       Impact factor: 9.910

Review 9.  Lesion analysis of the brain areas involved in language comprehension.

Authors:  Nina F Dronkers; David P Wilkins; Robert D Van Valin; Brenda B Redfern; Jeri J Jaeger
Journal:  Cognition       Date:  2004 May-Jun

10.  Pre- and postoperative intracarotid amytal procedure: an assessment of validity.

Authors:  Jessica Bramham; Robin G Morris
Journal:  Epilepsy Behav       Date:  2003-10       Impact factor: 2.937

View more
  6 in total

1.  Functional MRI and direct cortical stimulation: Prediction of postoperative language decline.

Authors:  Rachel Rolinski; Alison Austermuehle; Edythe Wiggs; Shubhi Agrawal; Leigh N Sepeta; William D Gaillard; Kareem A Zaghloul; Sara K Inati; William H Theodore
Journal:  Epilepsia       Date:  2019-02-11       Impact factor: 5.864

Review 2.  Comparing the Wada Test and Functional MRI for the Presurgical Evaluation of Memory in Temporal Lobe Epilepsy.

Authors:  Andreu Massot-Tarrús; Kevin White; Seyed M Mirsattari
Journal:  Curr Neurol Neurosci Rep       Date:  2019-05-01       Impact factor: 5.081

3.  Determination of language areas in patients with epilepsy using the super-selective Wada test.

Authors:  Kazuo Kakinuma; Shin-Ichiro Osawa; Hiroaki Hosokawa; Marie Oyafuso; Shoko Ota; Erena Kobayashi; Nobuko Kawakami; Kazushi Ukishiro; Kazutaka Jin; Makoto Ishida; Takafumi Sato; Mika Sakamoto; Kuniyasu Niizuma; Teiji Tominaga; Nobukazu Nakasato; Kyoko Suzuki
Journal:  IBRO Neurosci Rep       Date:  2022-08-10

4.  Roles of fMRI and Wada tests in the presurgical evaluation of language functions in temporal lobe epilepsy.

Authors:  Andreu Massot-Tarrús; Seyed M Mirsattari
Journal:  Front Neurol       Date:  2022-09-30       Impact factor: 4.086

Review 5.  Functional connectivity of hippocampus in temporal lobe epilepsy depends on hippocampal dominance: a systematic review of the literature.

Authors:  Camille K Milton; Christen M O'Neal; Andrew K Conner
Journal:  J Neurol       Date:  2021-02-10       Impact factor: 4.849

6.  A simple magnetoencephalographic auditory paradigm may aid in confirming left-hemispheric language dominance in epilepsy patients.

Authors:  Juha Wilenius; Henri Lehtinen; Ritva Paetau; Riitta Salmelin; Erika Kirveskari
Journal:  PLoS One       Date:  2018-07-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.